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The aim of this work was to examine the bioactivity and the conformational behavior of some gomesin (Gm) analogues in different
environments that mimic the biological membrane/water interface. Thus, manual peptide synthesis was performed by the solid-phase method,
antimicrobial activity was evaluated by a liquid growth inhibition assay, and conformational studies were performed making use of several
spectroscopic techniques: CD, fluorescence and EPR. [TOAC1]-Gm; [TOAC1, Ser2,6,11,15]-Gm; [Trp7]-Gm; [Ser2,6,11,15, Trp7]-Gm; [Trp9]-Gm;
and [Ser2,6,11,15, Trp9]-Gm were synthesized and tested. The results indicated that incorporation of TOAC or Trp caused no significant reduction of
antimicrobial activity; the cyclic analogues presented a β-hairpin conformation similar to that of Gm. All analogues interacted with negatively
charged SDS both above and below the detergent's critical micellar concentration (cmc). In contrast, while Gm and [TOAC1]-Gm required higher
LPC concentrations to bind to micelles of this zwitterionic detergent, the cyclic Trp derivatives and the linear derivatives did not seem to interact
with this membrane-mimetic system. These data corroborate previous results that suggest that electrostatic interactions with the lipid bilayer of
microorganisms play an important role in the mechanism of action of gomesin. Moreover, the results show that hydrophobic interactions also
contribute to membrane binding of this antimicrobial peptide.
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There is an increasing interest on the pharmacological
application of antimicrobial peptides (AMPs) to treat infections
due to the growing problem of pathogenic organisms resistant to
conventional antibiotics. AMPs are widely distributed in natureAbbreviations: AMP, antimicrobial peptide; CD, circular dichroism; cmc,
critical micelle concentration; EPR, electron paramagnetic resonance; LC/ESI-
MS, liquid chromatography electrospray ionization mass spectrometry; LPC,
lysophosphatidylcholine; MBHAR, 4-methylbenzhydrylamine-resin; NMR,
nuclear magnetic resonance; PB, poor broth; PDB, potato dextrose broth; RP-
HPLC, reversed phase high performance liquid chromatography; SDS, sodium
dodecyl sulfate; t-Boc, tert-butyloxycarbonyl; TEAP, triethylammonium
phosphate; TFA, trifluoroacetic acid; TFE, 2,2,2-trifluoroethanol; TOAC,
2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid
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doi:10.1016/j.bbamem.2006.08.016and represent an ancient host defense mechanism present in
organisms across the evolutionary spectrum. They are key
elements of the innate immune defense against bacteria, fungi
and other pathogenic agents, generally displaying minimal
toxicity towards mammalian cells [1,2].
Since the original report on cecropin [3] – the first
inducible antibacterial peptide isolated from an insect – a
large number of AMPs have been found, especially in
arthropods, over the last two decades (http://www.bbcm.univ.
trieste.it/~tossi/ pag1.htm). Most of these peptides share some
common features, such as low molecular weight (less than
5kDa), positive net charge (at physiological pH) and
amphipathic character. Among them, the cysteine-rich family
has been largely investigated in the past years [4], since the
maintenance of at least one intramolecular disulfide bridge
seems to be fundamental to maintain antimicrobial activity
[5,6].
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level, inducing membrane thinning, pore formation, and bilayer
disruption, depending on the molecular properties of both
peptide and membrane lipid. Some of these transmembrane
structures are termed wormholes or toroidal pores, membrane
channel or barrel-stave [2,7]. The initial interaction of cationic
AMP, such as the tachyplesins [8], with the membrane of
microorganisms involves the binding of the peptides parallel to
the membrane surface at the interface between the phospholipid
head groups and fatty acid chains of the outer monolayer. It
seems that some AMPs interact electrostatically with the
phospholipid head groups leading the disruption of the bacterial
inner membrane, whereas some others enter the cells inhibiting
the synthesis of specific macromolecules [9]. Thus, diverse
models proposed how the peptides reorient perpendicular to the
plane of the membrane and the consequences thereof, even
though the exact killing mechanism is not clearly understood.
Recently, a novel AMP – gomesin (Gm) – was purified and
characterized from hemocytes of the Brazilian spider Acanthos-
curria gomesiana [10]. The peptide contains eighteen residues,
including four cysteines that form two disulfide bridges: Cys2–15
and Cys6–11. The native molecule (ZCRRLCYKQRCVTYC-
RGR-NH2) has a molecular mass of 2270.4Da, contains a
pyroglutamic acid (Z) at the N-terminus and is amidated at the
C-terminus.
NMR studies confirmed that the structure of gomesin
consists of a well-resolved two-stranded antiparallel β-sheet
connected by a noncanonical β-turn [11]. It shows sequence
similarities to tachyplesin [12] and polyphemusin [13] from
horseshoe crabs and its structural features resemble those of
protegrins (AMPs isolated from porcine leukocytes [14]) and
androctonins (isolated from the blood of a scorpion [15]). A
comparison between the structures of all these AMPs brings
about several common features in the distribution of hydro-
phobic and hydrophilic residues. The N- and C-termini, the β-
turn and one face of the β-sheet are hydrophilic, whereas the
hydrophobicity of the other face depends on peptide sequence.
These similarities suggest that all molecules interact with
membranes in an analogous manner [11].
Gomesin is effective against Gram-positive and Gram-
negative bacteria, fungi, yeast, and it affects the viability of
the parasite Leishmania amazonensis [10]. Due to its strong
efficacy on a broad range of microorganisms, including human
pathogens, and to structural properties that confer the molecule
high stability, this peptide shows an interesting potential as a
model for conformational studies, especially in different solvent
environments (SDS, LPC and TFE) that mimic the biological
membrane/water interface.
Among the spectroscopic techniques available for the
investigation of the conformation and dynamics of peptides,
spin labeling electron paramagnetic resonance (EPR) has been
used to a considerable extent. This approach enjoyed notable
expansion following the introduction of the paramagnetic amino
acid 2,2,6,6-tetramethyl-piperidine-1-oxyl-4-amino-4-carboxylic
acid (TOAC), which, for the first time, allowed the incorporation
of the spin probe into the peptide via a peptide bond [16]. Owing to
these unique characteristics a number applications have appearedin the last years, both from our own [17,18] and from other groups
[19]. Besides being employed in structural studies of peptides,
TOAC has also been used advantageously to monitor peptide
chain assembly in polymer backbones [20,21]. As emphasized in
earlier reports, due to the special rigidity of its covalent bond to the
peptide molecule, the TOAC moiety is highly sensitive to the
peptide backbone conformation and dynamics. In addition,
fluorescence and circular dichroism (CD) spectroscopies are
very well known techniques to study peptide conformation [22].
The aim of this workwas to correlate structural and functional
properties of several gomesin analogues. The conformational
behavior of the peptides was investigated by means of
spectroscopic techniques: EPR, fluorescence and CD. EPR
spectra were obtained for the analogue containing TOAC as the
N-terminal residue of gomesin ([TOAC1]-Gm) and its
corresponding linear form, [TOAC1, Ser2,6,11,15]-Gm. Fluores-
cence studies were performed with tryptophan-labeled analo-
gues, [Trp7]-Gm and [Trp9]-Gm and their corresponding linear
analogues, [Ser2,6,11,15, Trp7]-Gm and [Ser2,6,11,15, Trp9]-Gm.
CD spectra were obtained for all analogues. The analogues were
synthesized chemically and characterized, and their antimicro-
bial activity was evaluated by a liquid growth inhibition assay
against B. megaterium, E. coli and C. albicans.
2. Materials and Methods
2.1. Microorganisms
Three microbial strains were used in this study: Escherichia coli SBS 363
was donated by P.L. Poquet (CEA, Paris, France); Candida albicans MDM8
and Bacillus megaterium were obtained from the collection of the Department
of Microbiology, Institute of Biomedical Sciences, University of São Paulo (São
Paulo, Brazil).
2.2. Chemicals
Nα-tert-butyloxycarbonyl (Boc) amino acids were from Bachem, Torrance,
CA. Solvents, SDS, LPC and reagents were from Sigma-Aldrich Co, St. Louis,
MO. DMF was distilled (over P2O5 and ninhydrin under reduced pressure)
before use. All chemicals met ACS standards.
2.3. Peptide synthesis
Peptides were synthesized manually by solid-phase methodology on 4-
methylbenzhydrylamine-resin (MBHAR) (0.8 mmol/g) using the t-Boc strategy
[23]. Due to the presence of five Arg (Tos), full deprotection and cleavage from
the resin were carried out using anhydrous HF treatment with anisole and
dimethyl sulfide (DMS) as scavengers during 2 h at 0 °C. Fmoc-TOAC was
synthesized in our laboratory, following the procedure published elsewhere
[16,24,25]. Disulfide bridge formation was achieved on crude peptides
following HF cleavage at pH 6.8–7.0 and 5 °C for 72 h. The resulting
lyophilized peptides were purified by preparative RP-HPLC (column Vydac C18
(25×250mm, 300 Å pore size, 15μm particle size) in two steps. The first was
performed by using TEAP pH 2.25 as solvent A and 60% CH3CN in A as
solvent B. The second step was carried out using 0.1% TFA/H2O as solvent A
and 60% CH3CN/H2O as solvent B. Pure peptides were characterized by amino
acid analysis and reverse-phase liquid chromatography coupled to mass
spectrometry electrospray ionization (LC/ESI-MS).
2.4. Antimicrobial activity
The microbial strains used were Bacillus megaterium (Gram-positive
bacteria), Escherichia coli (Gram-negative bacteria) and Candida albicans
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growth inhibition assay as described earlier [26]. Microbial growth was assessed
by changes in optical density of the culture suspension as an increase in A595nm.
The minimal inhibitory concentration (MIC) was determined after 16
h incubation at 30 °C. Cells (106CFU/mL) were incubated in PB or 1/2PDB
media, andMICs were expressed as the [a]–[b] interval of concentrations, where
[a] is the highest concentration tested at which the microorganisms grow and [b]
is the lowest concentration that causes 100% growth inhibition [27]. All
experiments were performed in triplicate.
2.5. CD studies
CD measurements were performed on a Jasco J-810 spectropolarimeter
thermostated at 20 °C and continually flushed with ultra-pure nitrogen. CD
spectra were recorded using a 1mm path length rectangular quartz cell, with four
accumulations at 50 nm/min scan speed, 8 s response time, 0.5 nm spectral
bandwidth and wavelength range of 260 to 190 nm. The spectra were obtained in
water, water: TFE (0–90%, v/v) and in the presence of SDS (1–50 mM) and LPC
(1–50 mM). Samples were prepared by diluting the peptides stock solutions
(1 mM solution in water, pH 4) to obtain a final concentration of 0.1mM. The
results are expressed in terms of molar ellipticity [θ] in units of degrees cm2
dmol−1.
2.6. EPR studies
EPR measurements were carried out at 9.5GHz in a Bruker ER 200D-SRC
spectrometer at room temperature (22±2 °C) using flat quartz cells. The
magnetic field was modulated with amplitudes less than one-fifth of the line
widths, and the microwave power was 5mW to avoid saturation effects.
Rotational correlation times, τC and τB, were calculated according to Schreier et
al. [28].
2.7. Fluorescence studies
Emission spectra were recorded on a Hitachi F4500 spectrofluorometer
linked to a PC microprocessor with Spectro WinLab software. The excitation
wavelength was 295nm, and the excitation and emission slit widths were 5 and
10 nm, respectively. Emission spectra were acquired in the 310–400 nm range at
1 nm increments with a scan speed of 20 nm/min at 25 °C. The peptide
concentrations were approximately 0.3 μM in water, while SDS and LPC
concentrations varied from 1 to 50 mM.
3. Results and discussion
The MICs of gomesin analogues against strains of bacteria
and yeast were determined using liquid growth inhibition assays
(Table 1). The linear analogues were always less active against
B. megaterium, E. coli. and C. albicans than the correspondingTable 1
Antimicrobial activity of gomesin and its analogues
Peptide
B. megaterium
Gomesin (Gm) 0.32–0.64
[TOAC1]-Gm 0.64–1.28 (2)
[TOAC1, Ser2,6,11,15]-Gm 2.56–5.12 (8)
[Trp7]-Gm 1.28–2.56 (4)
[Ser2,6,11,15, Trp 7]-Gm 2.56–5.12 (8)
[Trp9]-Gm 0.64–1.28 (2)
[Ser2,6,11,15, Trp9]-Gm 5.12–10.24 (16)
a MICs were obtained in Poor Broth (217 mOsM; 1.0 g Peptone+86 mM NaCl in 1
nutrients mediums. MICs were expressed as the interval of concentrations [a]–[b],
growing and [b] is the lowest concentration that causes 100% growth inhibition. Nucyclic ones, corroborating our previous data that revealed that at
least one disulfide bridge is essential to maintain gomesin
secondary structure and antimicrobial activity [6]. In fact, the
linear analogues were 8 to 32-fold less active than the native
peptide in all tests. On the other hand, the cyclic analogues were
almost as active as gomesin (up to 4-fold less active) in all
microorganism strains. Taken together these results indicate that
the incorporation of TOAC in position 1 or the replacement of
Tyr7 and Gln9 by Trp in the primary sequence of gomesin was
well tolerated and generated active analogues.
The above observations correlate very well with CD spectra
of the analogues (Fig. 1) that show that gomesin and the cyclic
analogues have the tendency to adopt β-turn conformation in
water, SDS (Fig. 1A and G), LPC (Fig. 1B and H), and TFE (Fig.
1C and I), as evinced by the strong negative band at 205 nm and
the positive one at 232 nm, characteristic of a β-hairpin-like
structure. Varying the environment did not significantly affect
their conformations, as observed in Fig. 1. Such features are
fundamental for the high efficacy of cyclic analogues against the
microorganisms tested.
The CD spectra of the linear analogues in water showed a
negative band at 198 nm, indicative of unordered structure (Fig.
1). When 1 mM SDS was added (Fig. 1D and J), the spectra
presented a positive band at 192 nm and a negative one at 216 nm,
characteristic ofβ-sheet conformation [29]. As the critical micelle
concentration (cmc) of this surfactant inwater is ca 8mM[30], the
CD spectra show that SDS monomers are able to induce drastic
conformational changes in the linear peptides. In addition,
increasing SDS concentrations did not cause additional significant
conformational modifications, even above the cmc.
In the presence of LPC micelles, spectra of the linear
analogues (Fig. 1E and K) showed a negative band at 198 nm,
indicating an unordered structure. These results suggest that
linear peptides did not interact with LPC, which was expected
because LPC carries a zwitterionic head group that does not
interact electrostatically with cationic peptides. Consequently,
increasing LPC concentration did not affect the conformation of
the peptides.
The spectra of the linear analogues in TFE (Fig. 1F and L)
evidenced the important contribution of this organic solvent to
conformation. As can be seen, a tendency to adopt α-helical
conformation with increasing TFE concentration was observed,MIC (μM) a
E. coli C. albicans
0.64–1.28 0.64–1.28
0.64–1.28 (1) 1.28–2.56 (2)
20.48–40.96 (32) 5.12–10.24 (8)
1.28–2.56 (2) 0.64–1.28 (1)
10.24–20.48 (16) 5.12–10.24 (8)
0.64–1.28 (1) 0.64–1.28 (1)
5.12–10.24 (8) 5.12–10.24 (8)
00 mL of H2O) or 1/2PDB (79 mOsM; 1.2 g potato dextrose in 100 mL of H2O)
where [a] is the highest concentration tested at which the microorganisms were
mbers in the parentheses mean: analogue MIC/gomesin MIC.
Fig. 1. CD spectra of [Trp9]-Gm (A, B, C), [Ser2,6,11,15, Trp9]-Gm (D, E, F), [TOAC1]-Gm (G, H, I) and [TOAC1, Ser2,6,11,15]-Gm (J, K, L) as a function of concentration
of SDS (A, D, G, J), LPC (B, E, H, K), and TFE (C, F, I, L). Gomesin in the presence of 1 mM SDS, 1 mM LPC, or 10% TFE (□); and in 50 mM SDS, 50 mM LPC, or
90% TFE (○). Peptides in: H2O, (
_); 1 mM SDS, 1 mM LPC, or 10% TFE, (◼); 10 mM SDS, 10 mM LPC, or 50% TFE, (▾); 50 mM SDS, 50 mM LPC, or 70% TFE,
(▴); and 90% TFE, (●). [Peptide]=0.1 mM.
55L.G.M. Moraes et al. / Biochimica et Biophysica Acta 1768 (2007) 52–58since the CD spectra present a strong positive band at 198 nm
and two negative bands at ca. 208 and 222 nm [31], mainly in
70% TFE. On the other hand, gomesin and the cyclic analogues
(Fig. 1C and I) retained the β-turn-like conformation even in
90% TFE. From these observations we concluded that the lack
of intramolecular disulfide bridges conferred high flexibility to
these peptides, in allowing the linear analogues to acquire α-
helical conformation.EPR spectroscopy was employed to study the TOAC-labeled
gomesin analogues in the presence of SDS and LPC. Fig. 2
shows the EPR spectra of [TOAC1]-Gm in solution and in the
presence of variable concentrations of SDS and LPC. It is seen
that the peptide interacts with both surfactants. The spectrum in
aqueous solution (A) presents three narrow lines, typical of fast
tumbling motion, as expected for a relatively low molecular
weight molecule. At 1 mM SDS the spectra (B) reveal the
Fig. 2. EPR spectra of 0.1 mM [TOAC1]-Gm: aqueous solution, (A); 1 mM SDS,
(B); 5 mM SDS, (C); 10 mM SDS, (D); 5 mM LPC, (E); and 50 mM LPC, (F).
The scan width is 100 Gauss.
Table 2
Calculated values of τC, τC/τB, and aN for the EPR spectra of [TOAC
1]-Gm and
[TOAC1, Ser2,6,11,15]-Gm in aqueous solution and in the presence of micelles
τC (×10
10 s) τC/τB aN (Gauss)
[TOAC1]-Gm
In solution 5.52 1.14 16.48
In 10mM SDS 19.80 1.56 16.61
In 50mM LPC 30.10 1.88 15.95
[TOAC1, Ser2,6,11,15]-Gm
In solution 2.68 1.15 16.45
In 50mM LPC 16.40 1.30 15.99
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(narrow triplet) and another showing broad lines, typical of a
strongly immobilized molecule. This SDS concentration is
much lower than the surfactant cmc (8 mM). Thus, the peptide
is capable of interacting with SDS monomers. This is clearly
evinced at 5 mM SDS (C), where a powder spectrum, due to
strongly immobilized peptide is obtained. Above the cmc, at
10mM SDS, the spectrum (D) corresponds to the peptide totally
bound to the micellar structure. This spectrum is still in the fast
motion regime but the observed line broadening is indicative of
the slower tumbling rate of the micelle-bound peptide.
The zwitterionic surfactant LPC was in the micellar form at
all concentrations used. However, [TOAC1]-Gm only gave rise
to a micelle-bound population in the sample containing 5 mM
surfactant. At this concentration, a two-component spectrum
was obtained (E), corresponding to free and micelle-bound
peptide. With increasing LPC concentration, the latter compo-
nent increased and, at 50 mM LPC, the spectrum (F) indicated
that [TOAC1]-Gm was essentially totally bound. Hence, higher
concentrations of zwitterionic LPC were required for total
binding.
Table 2 lists the values of τC, τC/τB, and aN for the spectra of
[TOAC1]-Gm in aqueous solution and when totally bound toSDS and LPC micelles, as well as those calculated for [TOAC1,
Ser2,6,11,15]-Gm in aqueous solution and when totally bound to
SDS (see below). It is seen that the rotational correlation time of
[TOAC1]-Gm increases considerably upon binding to micelles.
The larger τC value in the presence of LPC probably reflects the
micelle slower tumbling. The τC/τB values also increase in
going from water to micelle, indicating that the motion of the
peptide is more anisotropic. The values of the isotropic
hyperfine coupling constant are very similar in all cases,
suggesting that the peptide is located at the micelle–water
interface.
The EPR spectra of [TOAC1, Ser2,6,11,15]-Gm (not shown)
indicated that, while this peptide did not bind to LPC micelles, it
only bound to SDS above the cmc. Similarly to [TOAC1]-Gm,
the values of τC and τC/τB increased upon binding, and the
value of aN also pointed to interfacial location. It is worth
noticing that in aqueous solution τC for [TOAC
1]-Gm was
considerably larger than that of the linear analogue, reflecting
the more rigid structure of the disulfide-bridged β-hairpin.
The EPR data are in excellent agreement with CD spec-
troscopy. CD spectra for the peptide-SDS complex below the
cmc (Fig. 1G) show that [TOAC1]-Gm acquires a somewhat
different conformation under these conditions. It should be
recalled that the EPR spectrum (Fig. 2C) shows that the peptide
is strongly immobilized in this complex. With regard to LPC,
although the features of the β-hairpin are always present (Fig.
1H), the positive band in the 215–240nm region gradually
shifts to lower wavelengths, an event that parallels the EPR-
evinced gradual increase of the micelle-bound population.
As for [TOAC1, Ser2,6,11,15]-Gm, the correlation between
CD and EPR is also very good in that binding to LPC is not
observed and binding to SDS above the cmc is detected by both
techniques. The only exception was that, while EPR did not
evince a peptide–SDS interaction below the detergent cmc, a
conformational change was monitored by CD at 1 mM
surfactant.
The different behavior of the disulfide-bridged peptides
when compared to the linear ones can be rationalized by
analyzing the amphipathicity of their structures. As previously
noticed, the β-hairpin conformation of gomesin gives rise to an
amphipathic structure [11] which is maintained in the cyclic
analogues. In contrast, the linear derivatives are able to acquire
α-helical conformation in TFE (Fig. 1F and L). Since TFE is a
membrane-mimicking environment, one could expect that these
Fig. 3. Fluorescence emission spectra (λexc=295nm) of [Trp
9]-Gm (A, B) and of [Ser2,6,11,15, Trp9]-Gm (C, D) in the presence of SDS (A, C) and LPC (B, D), at 20 °C.
[Surfactant] (mM)=0 (▪), 1 (□), 5 (▾), 10 (Δ), and 50 (●).
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However, a helical wheel display of their sequences shows that
the helix they give rise to does not possess amphipathic
character. Instead, positively charged residues are spread over
the whole helix surface. This is very likely the explanation for
the fact that the linear Gm analogues bind to negatively charged
SDS but not to zwitterionic LPC.
Fluorescence studies were performed for [Trp9]-Gm and
[Ser2,6,11,15, Trp9]-Gm in the presence of SDS and LPC (Fig. 3).
Spectra of the free and bound peptides were compared. In water,
the Trp residue shows a peak of maximal fluorescence (λmax) at
ca. 359 nm [32].
Emission spectra of [Trp9]-Gm and [Ser2,6,11,15, Trp9]-Gm
showed that λmax changed in 1mM SDS. In fact, the transfer of
the peptide from the aqueous medium to the (less polar) micellar
environment, caused a blue-shift [22] from around 350 nm to
325 nm (Fig. 3A and C). On the other hand, an increase in LPC
concentration did not shift λmax, suggesting that the Trp-
containing peptide did not interact with the micellar aggregates
(Fig. 3B and D).
We do not have at present an explanation for the apparently
weak binding of [Trp9]-Gm to LPC micelles. As suggested by
both CD spectra (Fig. 1B) and the fluorescence results (Fig. 3B).
This behavior is in contrast with that of the other cyclic peptides—
Gm and [TOAC1]-Gm. While both CD (Fig. 1H) and EPR (Fig.
2, spectra E and F) spectra provided evidence for the interaction
between the latter peptides and LPC, only slight changes were
seen in the CD spectra (Fig. 1B) and no changes were seen in
fluorescence spectra (Fig. 3B) of [Trp9]-Gm with increasing
LPC concentration, suggesting that the interaction between
[Trp9]-Gm and these micelles is essentially non-existent.Moreover, in agreement with the data for the other linear
analogues, the linear Trp-substituted analogue also did not
interact with LPC (Fig. 1E). In contrast, the fluorescence spectra
do demonstrate that both the cyclic (Fig. 3A) and the linear (Fig.
3C) Trp-carrying analogues did interact with SDS both above
and below the cmc.
In this work, three spectroscopic techniques were employed
to examine the structure activity relationship for cyclic and linear
analogues of the AMP gomesin. The results showed that the
incorporation of TOAC or the replacement of Tyr7 or Gln9 by
Trp caused no significant reduction of gomesin antimicrobial
activity. Moreover, it was found that the more active cyclic
analogues presented a β-hairpin conformation similar to that of
gomesin in all environments, while the less active linear
analogues presented an unordered conformation in water. All
analogues strongly interacted with SDS, but not with LPC
micelles, with the exception of Gm and [TOAC1]-Gm, but in
both cases the interaction with this zwitterionic detergent
required higher concentration than when the negatively charged
SDS was used. These findings support previous suggestions that
the first step of the mechanism of action of gomesin should be an
electrostatic interaction with the lipid bilayer, causing the
disruption of the bacterial inner membrane. Moreover, our
results show that hydrophobic interactions also contribute to
membrane binding of this AMP.
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